详情页 - 河北医科大学第四医院机构库

当前位置：首页 > 详情页

Neoadjuvant immuno-chemoradiation in esophageal cancer: an individual patient data meta-analysis

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE

作者：

机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Radiat Oncol,Natl Canc Ctr, Beijing, Peoples R China [2]Univ Lancaster, Dept Math & Stat, Lancaster, England [3]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept VIP Med Serv,Natl Canc Ctr, Beijing, Peoples R China [4]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Thorac Surg,Natl Canc Ctr, Beijing, Peoples R China [5]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Pathol,Natl Canc Ctr, Beijing, Peoples R China [6]Hebei Med Univ, Hosp 4, Dept Radiotherapy, Shijianzhuang, Peoples R China

出处：

ISSN：

关键词： neoadjuvant esophageal meta-analysis

语种：

WOS：

中科院分区：

出版当年[2025]版：

大类 | 2 区

医学

小类 | 2 区肿瘤学 2 区核医学

最新[2025]版：

大类 | 2 区

医学

小类 | 2 区肿瘤学 2 区核医学

JCR分区：

出版当年[2024]版：

无

最新[2023]版：

Q1 ONCOLOGY Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

影响因子： 4.9 最新[2023版] 5.4 最新五年平均 4.9 出版当年[2024版] 5.4 出版当年五年平均 4.9 出版前一年[2023版]

第一作者：

第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Radiat Oncol,Natl Canc Ctr, Beijing, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Comparison of neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for esophageal cancer: a meta-analysis [2]我国食管癌二级预防的Meta-analysi [3]Neoadjuvant Immunotherapy Combined with Chemoradiation in Esophageal Cancer: An Individual Patient Data Meta -Analysis [4]Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer: A systematic review and meta-analysis [5]Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis [6]Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis [7]我国食管癌二级预防的Meta―analysis [8]A Commentary on "Efficacy and safety of neoadjuvant immunotherapy in surgically resectable esophageal cancer: A systematic review and meta-analysis" (Int J Surg 2022;104:106767) [9]A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer [10]Association of miR-21 with esophageal cancer prognosis: a meta-analysis